Today, Embla Medical's CEO, Sveinn Sölvason, presented the Q2 2026 results and outlined the key drivers behind them, as well as the adjusted 2026 guidance. Focus was also directed towards advancements in innovation and how these are driving growth.
You can watch a recording of the presentation here: https://www.inderes.dk/videos/embla-medical-presentation-of-the-h1-2026-interim-report
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR subscription agreement. /Victor Skriver, 12:16 21/07-2026
This content is only available for logged in users